Viewing StudyNCT00123630



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00123630
Status: COMPLETED
Last Update Posted: 2016-05-20
First Post: 2005-07-21

Brief Title: A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
Sponsor: University of Utah
Organization: University of Utah

Organization Data

Organization: University of Utah
Class: OTHER
Study ID: 13623
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Utah
Lead Sponsor Class: OTHER
Responsible Party: John C Fang MD
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: University of Utah
Old Name: None
Old Organization: None

Collaborators

Name Class
Novartis Pharmaceuticals INDUSTRY